市场调查报告书
商品编码
1554479
2024-2032 年日本蛋白质表现市场报告(按产品、应用、最终用户(学术研究机构、生物技术和製药公司、合约研究组织)和地区)Japan Protein Expression Market Report by Product, Application, End User (Academic Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations ), and Region 2024-2032 |
日本蛋白质表现市场规模预计在 2024 年至 2032 年期间将呈现 9.40% 的成长率 (CAGR)。基因工程技术的不断进步,例如 CRISPR-Cas9,使改造细胞以改善蛋白质表现变得更加容易,正在推动市场发展。
蛋白质表现是指利用基因编码的讯息在活细胞内合成功能性蛋白质的过程。基因是 DNA 片段,包含建构特定蛋白质的指令,蛋白质表现是生物体执行各种功能的基本生物机制。蛋白质表现过程涉及两个主要步骤:转录和翻译。在转录过程中,DNA 片段被复製到细胞核中称为信使 RNA (mRNA) 的分子中。这种 mRNA 分子将遗传密码携带到位于细胞质中的细胞蛋白质製造机器。在翻译步骤中,核醣体和转移RNA (tRNA) 共同读取mRNA 程式码并将相应的胺基酸组装成多肽链,然后折迭成功能性蛋白质。蛋白质表现对于多种生物过程至关重要,包括细胞生长、组织修復、免疫反应和酵素反应。研究人员经常操纵蛋白质表现来研究基因功能或生产用于医学和生物技术目的的特定蛋白质,例如疫苗开发或胰岛素等治疗性蛋白质的生产。
由于几个关键驱动因素,日本的蛋白质表现市场正在经历显着成长。首先,生物製药需求的成长是市场扩张的主要催化剂。随着製药业不断转向生物製品的开发,对高效蛋白质表现系统来生产这些复杂的治疗性蛋白质的需求越来越大。此外,蛋白质表现领域的技术进步在市场扩张中发挥了关键作用。重组DNA技术和高通量筛选等创新技术和平台提高了蛋白质表现过程的效率和可扩展性。这些进步不仅降低了生产成本,也加快了新生物製药的开发时间表。此外,癌症和自体免疫疾病等慢性疾病的日益流行,增加了对基于蛋白质的诊断和治疗的需求,预计将在预测期内推动日本的蛋白质表现市场。
IMARC Group提供了每个细分市场的主要趋势的分析,以及 2024-2032 年国家层级的预测。我们的报告根据产品、应用和最终用户对市场进行了分类。
该报告根据产品提供了详细的市场细分和分析。这包括试剂和试剂盒(无细胞表达、细菌表达、酵母表达、藻类表达、昆虫表达、哺乳动物表达等)、服务等。
报告还提供了基于应用程式的详细市场细分和分析。这包括治疗、工业和研究。
该报告提供了基于最终用户的详细市场细分和分析。这包括学术研究机构、生物技术和製药公司以及合约研究组织 (CRO)。
该报告还对所有主要区域市场进行了全面分析,包括关东地区、关西/近畿地区、中部/中部地区、九州冲绳地区、东北地区、中国地区、北海道地区和四国地区。
市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。
此处未提供公司名称,因为这是目录范例。最终报告中将提供完整的清单。
Japan protein expression market size is projected to exhibit a growth rate (CAGR) of 9.40% during 2024-2032. The ongoing advancements in genetic engineering technologies, such as CRISPR-Cas9, which have made it easier to engineer cells for improved protein expression, are driving the market.
Protein expression refers to the process by which information encoded in a gene is used to synthesize a functional protein within a living cell. Genes are segments of DNA that contain the instructions for building specific proteins, and protein expression is a fundamental biological mechanism that allows organisms to carry out various functions. The process of protein expression involves two main steps: transcription and translation. During transcription, a DNA segment is copied into a molecule called messenger RNA (mRNA) in the cell's nucleus. This mRNA molecule carries the genetic code to the cell's protein-making machinery, located in the cytoplasm. In the translation step, ribosomes and transfer RNA (tRNA) work together to read the mRNA code and assemble the corresponding amino acids into a polypeptide chain, which then folds into a functional protein. Protein expression is essential for a wide range of biological processes, including cell growth, tissue repair, immune responses, and enzymatic reactions. Researchers often manipulate protein expression to study gene function or produce specific proteins for medical and biotechnological purposes, such as vaccine development or the production of therapeutic proteins like insulin.
The protein expression market in Japan is experiencing significant growth due to several key drivers. Firstly, the rising demand for biopharmaceuticals has been a major catalyst for market expansion. As the pharmaceutical industry continues to shift towards the development of biologics, there is an increasing need for efficient protein expression systems to produce these complex therapeutic proteins. Moreover, technological advancements in the field of protein expression have played a pivotal role in market expansion. Innovative techniques and platforms, such as recombinant DNA technology and high-throughput screening, have enhanced the efficiency and scalability of protein expression processes. These advancements have not only reduced production costs but also accelerated the development timelines for new biopharmaceuticals. Furthermore, the growing prevalence of chronic diseases, such as cancer and autoimmune disorders, which has bolstered the demand for protein-based diagnostics and therapeutics, is expected to drive the protein expression market in Japan during the forecast period.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, application, and end user.
The report has provided a detailed breakup and analysis of the market based on the product. This includes reagents and kits (cell-free expression, bacterial expression, yeast expression, algal expression, insect expression, mammalian expression, and others), service, and others.
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes therapeutic, industrial, and research.
The report has provided a detailed breakup and analysis of the market based on the end user. This includes academic research institutes, biotechnology and pharmaceutical companies, and contract research organizations (CROs).
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.